Market Overview:
The global chemiluminescence immunoassay (Clia) analyzers market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for Clia analyzers for various applications such as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing and autoimmune diseases. Additionally, the growing demand for fully automated Clia analyzers is also contributing to the growth of this market. However, factors such as high cost of fully automated Clia analyzers and lack of skilled professionals are restraining the growth of this market.
 Analyzers Industry Outlook.svg)
Product Definition:
A chemiluminescence immunoassay (CLIA) analyzer is a machine used to detect and measure the amount of a particular substance in a sample. This type of analyzer is often used in medical laboratories to test for things like blood sugar levels, cholesterol levels, and hormone levels.
Semi-Automated Clia Analyzers:
Semi-automatic clia analyzers are used for the quantitative determination of a wide range of biomolecules such as proteins, nucleic acids, and vitamins in biological fluids. The introduction of technologically advanced products is expected to drive the market over the forecast period.
The U.S., Canada, Japan, Germany and France are major countries with high healthcare expenditure; thus boosting demand for clinical laboratory testing globally.
Fully Automated Clia Analyzers:
The fully automated Clia analyzers and it's usage in chemiluminescence immunoassay (Clia) analyzers market is expected to grow at a significant pace during the forecast period. Fully Automated Clia Analyzer (FACTA) is an innovative solution that offers high performance, accuracy, and reliability for clinical laboratory applications such as molecular diagnostics tests. It reduces labor costs by eliminating the need for a trained operator by performing all critical operations automatically.
Application Insights:
The others application segment includes neurology, toxicology, and diabetes testing. The demand for clia analyzers is expected to grow owing to the increasing prevalence of chronic diseases such as cancer, autoimmune disease & infections. In addition, a rise in drug discovery and development activities is anticipated to boost the product demand over the forecast period.
Clinical research is also expected to be one of the key growth drivers due to an increase in R&D activities pertaining diagnostics tests for new drug development purposes across several companies involved in various stages of clinical trials. This has resulted in an increased number of Clia test orders from different research facilities globally which will drive market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as increasing adoption of advanced technologies, rising prevalence of chronic diseases, and high demand for cost-effective & accurate diagnostic tests. Moreover, presence of a large number of players in this region is expected to provide ample opportunities for new entrants.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rapid economic development coupled with improving healthcare infrastructure & availability of cost-effective Clia test kits. In addition, growing awareness about early diagnosis and treatment options will drive regional market growth during the forecast period.
Growth Factors:
- Increasing demand for early and accurate diagnosis of diseases
- Technological advancements in Clia analyzers
- Growing number of clinical laboratories and hospitals
- Rising prevalence of chronic diseases
- Increasing awareness about benefits of Clia analyzers
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemiluminescence Immunoassay (Clia) Analyzers Market Research Report
By Type
Semi-Automated Clia Analyzers, Fully Automated Clia Analyzers
By Application
Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease, Others
By Companies
Roche Diagnostics, Abbott, Siemens Healthcare, Ortho Clinical Diagnostics, Beckman Coulter, Snibe, DiaSorin, Luminex Corporation, Tosoh Bioscience, Sysmex, Roche Diagnostics, Mindray
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Chemiluminescence Immunoassay (Clia) Analyzers Market Report Segments:
The global Chemiluminescence Immunoassay (Clia) Analyzers market is segmented on the basis of:
Types
Semi-Automated Clia Analyzers, Fully Automated Clia Analyzers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abbott
- Siemens Healthcare
- Ortho Clinical Diagnostics
- Beckman Coulter
- Snibe
- DiaSorin
- Luminex Corporation
- Tosoh Bioscience
- Sysmex
- Roche Diagnostics
- Mindray
 Analyzers Market Overview.svg)
Highlights of The Chemiluminescence Immunoassay (Clia) Analyzers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Semi-Automated Clia Analyzers
- Fully Automated Clia Analyzers
- By Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemiluminescence Immunoassay (Clia) Analyzers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Analyzers Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemiluminescence immunoassay (Clia) analyzers are a type of laboratory instrument that uses light to measure the amount of a specific substance in a sample. The Clia instrument emits short, intense flashes of light when it detects the presence of specific substances in the sample. This technology is often used to test for the presence of drugs and other chemicals in biological samples.
Some of the major companies in the chemiluminescence immunoassay (clia) analyzers market are Roche Diagnostics, Abbott, Siemens Healthcare, Ortho Clinical Diagnostics, Beckman Coulter, Snibe, DiaSorin, Luminex Corporation, Tosoh Bioscience, Sysmex, Roche Diagnostics, Mindray.
The chemiluminescence immunoassay (clia) analyzers market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chemiluminescence Immunoassay (Clia) Analyzers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chemiluminescence Immunoassay (Clia) Analyzers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chemiluminescence Immunoassay (Clia) Analyzers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chemiluminescence Immunoassay (Clia) Analyzers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chemiluminescence Immunoassay (Clia) Analyzers Market Size & Forecast, 2020-2028
4.5.1 Chemiluminescence Immunoassay (Clia) Analyzers Market Size and Y-o-Y Growth
4.5.2 Chemiluminescence Immunoassay (Clia) Analyzers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Semi-Automated Clia Analyzers
5.2.2 Fully Automated Clia Analyzers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Therapeutic Drug Monitoring
6.2.2 Oncology
6.2.3 Cardiology
6.2.4 Endocrinology
6.2.5 Infectious Disease Testing
6.2.6 Autoimmune Disease
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chemiluminescence Immunoassay (Clia) Analyzers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chemiluminescence Immunoassay (Clia) Analyzers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Semi-Automated Clia Analyzers
9.6.2 Fully Automated Clia Analyzers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Therapeutic Drug Monitoring
9.10.2 Oncology
9.10.3 Cardiology
9.10.4 Endocrinology
9.10.5 Infectious Disease Testing
9.10.6 Autoimmune Disease
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Semi-Automated Clia Analyzers
10.6.2 Fully Automated Clia Analyzers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Therapeutic Drug Monitoring
10.10.2 Oncology
10.10.3 Cardiology
10.10.4 Endocrinology
10.10.5 Infectious Disease Testing
10.10.6 Autoimmune Disease
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Semi-Automated Clia Analyzers
11.6.2 Fully Automated Clia Analyzers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Therapeutic Drug Monitoring
11.10.2 Oncology
11.10.3 Cardiology
11.10.4 Endocrinology
11.10.5 Infectious Disease Testing
11.10.6 Autoimmune Disease
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Semi-Automated Clia Analyzers
12.6.2 Fully Automated Clia Analyzers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Therapeutic Drug Monitoring
12.10.2 Oncology
12.10.3 Cardiology
12.10.4 Endocrinology
12.10.5 Infectious Disease Testing
12.10.6 Autoimmune Disease
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Semi-Automated Clia Analyzers
13.6.2 Fully Automated Clia Analyzers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Therapeutic Drug Monitoring
13.10.2 Oncology
13.10.3 Cardiology
13.10.4 Endocrinology
13.10.5 Infectious Disease Testing
13.10.6 Autoimmune Disease
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chemiluminescence Immunoassay (Clia) Analyzers Market: Competitive Dashboard
14.2 Global Chemiluminescence Immunoassay (Clia) Analyzers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Abbott
14.3.3 Siemens Healthcare
14.3.4 Ortho Clinical Diagnostics
14.3.5 Beckman Coulter
14.3.6 Snibe
14.3.7 DiaSorin
14.3.8 Luminex Corporation
14.3.9 Tosoh Bioscience
14.3.10 Sysmex
14.3.11 Roche Diagnostics
14.3.12 Mindray
